Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults-Reference-Cited by-同舟云学术

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults

Published:2011-08 Issue:34 Volume:29 Page:5666-5674
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Frenck Robert W.,Belshe Robert,Brady Rebecca C.,Winokur Patricia L.,Campbell James D.,Treanor John,Hay Christine M.,Dekker Cornelia L.,Walter Emmanuel B.,Cate Thomas R.,Edwards Kathryn M.,Hill Heather,Wolff Mark,LeDuc Tom,Tornieporth Nadia

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference20 articles.

1. Impact of the 2004–2005 influenza vaccine shortage on pediatric practice: a national survey;McQuillan;Pediatrics,2009

2. Experiences with obtaining influenza vaccination among persons in priority groups during a vaccine shortage—United States, October–November, 2004;MMWR,2004

3. Influenza vaccine shortage hits the USA;Nelson;Lancet,2003

4. CDC expects early-season shortage of influenza vaccine supply chain should plan for delays;Traynor;Am J Health Syst Pharm,2001

5. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines;Alarcon;Clin Vaccine Immunol,2007

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of applying influenza-antigen-coated microneedles to rat skin and the antigen specific immune response in vivo;Journal of Pharmaceutical Investigation;2024-03-07

2. A Predictive Model of Vaccine Reactogenicity Using Data from an In Vitro Human Innate Immunity Assay System;The Journal of Immunology;2024-01-26

3. Microneedle-Mediated Immunization Promotes Lung CD8+ T-Cell Immunity;Journal of Investigative Dermatology;2023-10

4. Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial;Vaccine;2022-03

5. Microneedles enable the development of skin-targeted vaccines against coronaviruses and influenza viruses;Pharmaceutical Development and Technology;2021-12-08